BlackRock Health Sciences Term Trust
 
 
 
 
基本資料
種類: ETF
費用比率%: 1.37
資產淨值: 16.63
成立日期: 29/01/2020
 
分析
市值分佈:
49.01%
大市值
2.57%
中市值
0.84%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 77  
0%
 
100%
     10大 (21.47%)
代號 名稱 佔比% 持有日期
DXCMDexCom1.0931/12/2025
NBIXNeurocrine Biosciences1.0731/12/2025
LHLabcorp Holdings Inc.1.0630/09/2025
BBIOBridgeBio Pharma0.9931/12/2025
ARGXargenx SE0.9531/12/2025
TECHBio-Techne Corp0.9531/12/2025
EXELExelixis0.8731/12/2025
WSTWest Pharmaceutical Services0.8731/12/2025
DGXQuest Diagnostics0.8030/09/2025
MTHRFM3, Inc.0.7630/09/2025
QGENQiagen NV0.7031/12/2025
PTGXProtagonist Therapeutics0.5731/12/2025
PENPenumbra0.5531/12/2025
AXSMAxsome Therapeutics0.5031/12/2025
NUVLNuvalent0.5031/12/2025
ROIVRoivant Sciences Ltd0.4931/12/2025
ONCBeOne Medicines Ltd0.4331/12/2025
HALOHalozyme Therapeutics0.4031/12/2025
STOKStoke Therapeutics0.4031/12/2025
INCYIncyte Corp0.3831/12/2025
  1   2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.